Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W C Rose

Showing results (41-50 of 97) with videos related to

Pageof 10
Sort By:
Cancer Treatment Reports|August 1, 1979
Evaluation of whole-body hyperthermia as an adjunct to chemotherapy in murine tumorsW C Rose, G H Veras, W R Laster, et al.
Cancer Research|April 1, 1983
Experimental antitumor activity and toxicity of a new chemotherapeutic agent, BBM 928AW C Rose, J E Schurig, J B Huftalen, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1993
Preclinical antitumor activity of orally administered platinum (IV) complexesW C Rose, A R Crosswell, J E Schurig, et al.
Cancer Treatment Reports|January 1, 1982
Antitumor activity and toxicity of cisplatin analogsW C Rose, J E Schurig, J B Huftalen, et al.
Journal of the National Cancer Institute|March 21, 1990
In vivo antitumor activity of 9-[(2-phosphonylmethoxy)ethyl]-guanine and related phosphonate nucleotide analoguesW C Rose, A R Crosswell, J J Bronson, et al.
Cancer Treatment Reports|May 1, 1978
Comparative antitumor activity of actinomycin analogs in mice bearing Ridgway osteogenic sarcoma or P388 leukemiaW C Rose, M W Trader, W R Laster, et al.
Experimental Hematology|May 1, 1978
Graft versus leukemia. VIII. Selective reduction in antihost reactivity without loss of antileukemic reactivity by treatment of donor mice with lipopolysaccharideR L Truitt, W C Rose, A A Rimm, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1997
Preclinical antitumor activity of water-soluble paclitaxel derivativesW C Rose, J L Clark, F Y Lee, et al.
Transplantation|September 1, 1974
Graft-versus-leukemia. V. Absence of antileukemic effect using allogeneic h-2-identical immunocompetent cellsM M Bortin, A A Rimm, W C Rose, et al.
In Vivo (Athens, Greece)|January 1, 1987
In vivo characterization of P388 leukemia resistant to mitomycin CW C Rose, J B Huftalen, W T Bradner, et al.
Pageof 10

Showing results (41-50 of 97) with videos related to

Sort By:
Pageof 10
Cancer Treatment Reports|August 1, 1979
Evaluation of whole-body hyperthermia as an adjunct to chemotherapy in murine tumorsW C Rose, G H Veras, W R Laster, et al.
Cancer Research|April 1, 1983
Experimental antitumor activity and toxicity of a new chemotherapeutic agent, BBM 928AW C Rose, J E Schurig, J B Huftalen, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1993
Preclinical antitumor activity of orally administered platinum (IV) complexesW C Rose, A R Crosswell, J E Schurig, et al.
Cancer Treatment Reports|January 1, 1982
Antitumor activity and toxicity of cisplatin analogsW C Rose, J E Schurig, J B Huftalen, et al.
Journal of the National Cancer Institute|March 21, 1990
In vivo antitumor activity of 9-[(2-phosphonylmethoxy)ethyl]-guanine and related phosphonate nucleotide analoguesW C Rose, A R Crosswell, J J Bronson, et al.
Cancer Treatment Reports|May 1, 1978
Comparative antitumor activity of actinomycin analogs in mice bearing Ridgway osteogenic sarcoma or P388 leukemiaW C Rose, M W Trader, W R Laster, et al.
Experimental Hematology|May 1, 1978
Graft versus leukemia. VIII. Selective reduction in antihost reactivity without loss of antileukemic reactivity by treatment of donor mice with lipopolysaccharideR L Truitt, W C Rose, A A Rimm, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1997
Preclinical antitumor activity of water-soluble paclitaxel derivativesW C Rose, J L Clark, F Y Lee, et al.
Transplantation|September 1, 1974
Graft-versus-leukemia. V. Absence of antileukemic effect using allogeneic h-2-identical immunocompetent cellsM M Bortin, A A Rimm, W C Rose, et al.
In Vivo (Athens, Greece)|January 1, 1987
In vivo characterization of P388 leukemia resistant to mitomycin CW C Rose, J B Huftalen, W T Bradner, et al.
Pageof 10